Dr. Reddy’s Laboratories launches heart drug in the US

dr-reddy'sPharma company Dr. Reddy’s Laboratories Ltd said it launched Nitroglycerin sublingual tablets — a therapeutic equivalent generic version of Nitrostat sublingual tablets — in the US market.

The medication is used before physical activities (such as exercise, sexual activity) to prevent chest pain (angina) in people with a certain heart condition (coronary artery disease). It may also be used to relieve chest pain in these people once it occurs.

¨The Nitrostat ((Nitroglycerin) sublingual tablet brand had U.S. sales of approximately $108 Million MAT for the most recent twelve months ending in March 2016 according to IMS Health¨.

Dr. Reddy’s Laboratories Ltd., is an India-based pharma company and offers products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.

Dr. Reddyś focus on gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Major markets include – USA, India, Russia & CIS countries, and Europe.